|
Saddle River, NJ— (October 20, 2005) PDI, Inc. (NASDAQ: PDII) a diversified sales and marketing services provider to the biopharmaceutical and medical devices and diagnostics industries, announced the hire of Tim Shalbrack as Senior Vice President of Sales, responsible for leading PDI's Performance Teams programs. Shalbrack reports directly to PDI President, Steve Budd.
Shalbrack will be responsible for the execution of superior sales efforts by PDIs Performance Sales Teams, including support and talent development of the sales management team, working closely with the company's HR and IT centers of excellence to do so. PDI's current Sales Vice Presidents and General Managers report directly to Shalbrack.
"This is a wonderful opportunity to expand our culture of training and development within our sales organization, " states Shalbrack. "We have always been a market leader, and I am attracted by the opportunity to widen our opportunities through development of our own organization."
Shalbrack brings to the job over 26 years of pharmaceutical experience, 22 of which were in sales management roles of increasing scope and responsibility. Shalbrack has an MBA from Cardinal Stritch College in Milwaukee, WI.
"PDI is committed to having the best trained sales associates and management teams. We believe that Tim's strong, positive leadership style will be an asset to our entire organization." said Steve Budd.
For more information contact:
Stephen P. Cotugno
Executive Vice President-Corporate Development
PDI, Inc.
201-574-8617
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry. PDI's comprehensive set of outsourced sales and marketing solutions is designed to increase its clients' strategic flexibility and enhance their efficiency and profitability. Headquartered in Saddle River, NJ, PDI also has offices in Pennsylvania and Illinois.
PDI's sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients; and Select Access™, our targeted sales solution that leverages an existing infrastructure; marketing research and consulting; and medical education and communications. The company's experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continued innovation.
For more information, visit the Company's website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of
any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
